(NASDAQ: NXGL) Nexgel's forecast annual revenue growth rate of 29.21% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.79%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Nexgel's revenue in 2025 is $11,665,000.On average, 3 Wall Street analysts forecast NXGL's revenue for 2025 to be $98,540,052, with the lowest NXGL revenue forecast at $94,680,207, and the highest NXGL revenue forecast at $101,439,008. On average, 3 Wall Street analysts forecast NXGL's revenue for 2026 to be $140,216,607, with the lowest NXGL revenue forecast at $134,711,849, and the highest NXGL revenue forecast at $144,337,032.
In 2027, NXGL is forecast to generate $204,921,942 in revenue, with the lowest revenue forecast at $196,892,813 and the highest revenue forecast at $210,956,003.